Use of products in capital punishment
We object in the strongest possible terms to the use of any of our products for the purpose of capital punishment. Not only is it contrary to the intended label use(s) for the products, but it is also inconsistent with our values and mission of improving lives by providing quality, affordable healthcare to patients.
Drug shortages statement
Drug shortages are unfortunately occurring with increasing frequency, and they are something we take very seriously because of the negative impact on patient care. As a provider of critical pharmaceutical products, we understand the important role we have in helping to alleviate shortage situations.
Anti-bribery and corruption policy
We have a zero tolerance policy for bribery and corruption. As one of the founding members of the global Partnering Against Corruption Initiative, an offshoot of the World Economic Forum, we commit to a programme that fights bribery and corruption.
Modern Slavery Act
We are committed to ensuring that forced or compulsory labour and human trafficking does not take place in our businesses or supply chains. Throughout the world. As part of our commitment we train our employees on labour standards and how to recognise and respond to any incidences of modern slavery. We also analyse and manage any modern slavery risk in our company and supply chains, engaging with our suppliers on the issue and performing due diligence. In addition, we are a signatory to the United Nations Global Compact (UNGC), with a commitment to abide by the UNGC’s ten universally accepted principles which include human rights.
Group Environmental, Health and Safety Policy
As a leading global pharmaceutical company whose purpose is putting better health within reach every day, Hikma is committed to providing our employees with a safe and healthy workplace.